Search

Your search keyword '"Durand, Geoffroy"' showing total 249 results

Search Constraints

Start Over You searched for: Author "Durand, Geoffroy" Remove constraint Author: "Durand, Geoffroy"
249 results on '"Durand, Geoffroy"'

Search Results

4. Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinoma

5. Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA

6. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

7. Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer

8. Gradual transition towards anaplasia in Wilms tumor through tolerance to genetic damage

9. Sex specific associations in genome wide association analysis of renal cell carcinoma

11. Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

12. Figure S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

13. Data from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

14. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility

15. Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

16. Supplementary Figure S2 from Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid

17. Supplemental Material (for review only) File - Supplementary Tables 1-5. from Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid

18. Supplementary Methods from Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid

19. Supplementary Figure legends from Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid

20. Data from Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid

21. First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali

22. Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma

23. CASP9 germline mutation in a family with multiple brain tumors

24. Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma

26. Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort

28. Development of a Custom NGS Panel for the Determination of Bladder Cancer Risk

29. Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation

30. Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation

31. Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer

32. Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study

33. Merkel Cell Polyomavirus Downregulates N-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration

34. Sex specific associations in genome wide association analysis of renal cell carcinoma

35. Genomic analysis of head and neck cancer cases from two high incidence regions

36. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection

37. Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma

38. Genome-wide association study identifies multiple risk loci for renal cell carcinoma

39. CASP9 germline mutation in a family with multiple brain tumors

40. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility

41. Interplay between the epigenetic enzyme lysine (K)-specific demethylase 2B and Epstein-Barr virus infection

42. Abstract 5358: Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma

43. Genomic analysis of head and neck cancer cases from two high incidence regions

44. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility

45. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines

46. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation

47. CASP9 germline mutation in a family with multiple brain tumors

48. Marine monitoring campaign in France and French overseas departments: more than 10 000 datasets from grab and passive sampling

50. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

Catalog

Books, media, physical & digital resources